MedTrace Logo

Unilateral Transversus Abdominis Plane Block in Pediatrics

NCT04539314 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-08-01

No results posted yet for this study

Summary

the present study was designed to compare the efficacy and safety of two different doses of dexmedetomidine as an adjuvant to bupivacaine in unilateral TAP block in pediatric patients undergoing lower abdominal surgery.

Conditions

  • Unilateral TAP Block in Pediatric Patients Undergoing Lower Abdominal Surgery

Interventions

DRUG

Bupivacain

We will carry out the TAP block using 0.5 ml/ kg bupivacaine 0.25%

DRUG

Dexmedetomidine o.5 μg

We will carry out the TAP block using using 0.5 ml/ kg bupivacaine 0.25% with dexmedetomidine 0.5 μg / kg

DRUG

Dexmedetomidine 1 μg

We will carry out the TAP block using using 0.5 ml/ kg bupivacaine 0.25% with dexmedetomidine 1 μg / kg

Sponsors & Collaborators

  • Minia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2020-12-26
Completion
2020-12-30

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04539314 on ClinicalTrials.gov